Gallstones and Concomitant Gastric Helicobacter Pylori Infection
Study of Relationship Between Gallstones and Concomitant Gastric Helicobacter Pylori Infection
1 other identifier
observational
94
1 country
1
Brief Summary
In this study, the presence of H.Pylori in the gallbladder mucosa of patients with symptomatic gallstones undergoing cholecystectomy was investigated. Concomitant H.Pylori infection of the gastric mucosa was also investigated to study the relationship of gastric H.Pylori infection to gallstones. It was hypothesized that H.Pylori infection of the gastric mucosa may have a role in the formation of gallstones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 6, 2013
CompletedFirst Posted
Study publicly available on registry
March 13, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedMarch 13, 2013
March 1, 2013
2 months
March 6, 2013
March 11, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gallstones and concomitant H.Pylori infection of the gastric mucosa
The relationship between gastric H.Pylori infection and comcomitant gallstones will be evaluated
3 months
Study Arms (1)
cholecystectomy
cholecystectomy group: H.Pylori infection in gall bladder
Eligibility Criteria
Ninety-four patients with symptomatic gallstones undergoing laparoscopic cholecystectomy were enrolled for the study.
You may qualify if:
- Patients with acute cholecystitis, cholangitis, biliary and hepatic tumors, Crohn's disease, and previous gastric surgery were not considered suitable for evaluation.
You may not qualify if:
- Patients undergoing ERCP (endoscopic retrograde cholangio-pancreatography) and patients who have received H.Pylori eradication treatment in the last 6 month were also excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
marmara University School of Medicine
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
A.Ozdemir Aktan, md,PROF
Marmara University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist.Prof.
Study Record Dates
First Submitted
March 6, 2013
First Posted
March 13, 2013
Study Start
March 1, 2013
Primary Completion
May 1, 2013
Study Completion
June 1, 2013
Last Updated
March 13, 2013
Record last verified: 2013-03